The agency encourages reporting of illegally marketed substances.
The U.S. Food and Drug Administration (FDA) has issued a warning for the public and healthcare providers regarding the risks associated with products containing live bacteria or yeast, known as probiotics, for preterm infants in hospital settings. Probiotic products, categorized as foods or dietary supplements, contain live organisms like bacteria or yeast.
“Adverse events in any infant following the use of a probiotic are a concern to the FDA. We especially want to make clear that products containing live microorganisms may present serious risks to preterm infants in hospital settings,” said FDA’s Center for Biologics Evaluation and Research Director Peter Marks.
The agency is investigating adverse events related to these products and urges healthcare providers, caregivers, and parents to be aware of associated risks.
As the Lord Leads, Pray with Us…
- For Director Marks as he raises awareness regarding the risks of probiotics for preemies.
- For Commissioner Califf as he heads the Food and Drug Administration.
- For the parents and doctors of preterm infants as they seek to ensure the best care.
Sources: Reuters
